Additionally, considering the complicate intra- and inter-tumor heterogeneity, the successful applications of EGFR-TKIs to other cancers are less certain, largely because these kinase-activating mutations and T790M frequently occur in NSCLC and glioblastoma, but are rarely found in other types of cancers [19, 20]. Here, EGFR is linked to cancer.